|
Marinaro, M; Boyaka, P N; Jackson, R J et al. (1999) Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin. J Immunol 162:114-21
|
|
Marinaro, M; Boyaka, P N; Finkelman, F D et al. (1997) Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med 185:415-27
|
|
Fujihashi, K; Kweon, M N; Kiyono, H et al. (1997) A T cell/B cell/epithelial cell internet for mucosal inflammation and immunity. Springer Semin Immunopathol 18:477-94
|
|
Yamamoto, S; Kiyono, H; Yamamoto, M et al. (1997) A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci U S A 94:5267-72
|
|
Pascual, D W; Coste, M; Boyaka, P N et al. (1997) Spontaneously hypertensive rat: cholera toxin converts suppression to immunity through a Th2 cell-IL-4 pathway. Am J Physiol 273:R1509-18
|
|
Vancott, J L; Kweon, M; Fujihashi, K et al. (1997) Helper T subsets and cytokines for mucosal immunity and tolerance. Behring Inst Mitt :44-52
|
|
Yamamoto, S; Takeda, Y; Yamamoto, M et al. (1997) Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J Exp Med 185:1203-10
|
|
van Ginkel, F W; Pascual, D W (1996) Recognition of neurokinin 1 receptor (NK1-R): an antibody to a peptide sequence from the third extracellular region binds to brain NK1-R. J Neuroimmunol 67:49-58
|
|
Takahashi, I; Marinaro, M; Kiyono, H et al. (1996) Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis 173:627-35
|
|
VanCott, J L; Staats, H F; Pascual, D W et al. (1996) Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol 156:1504-14
|
Showing the most recent 10 out of 73 publications
